Asian Journal of Multidimensional Research (AJMR)
Year : 2018, Volume : 7, Issue : 8
First page : ( 7) Last page : ( 14)
Online ISSN : 2278-4853.

An empirical study on the sustainable growth rate of pharmaceutical companies listed in nifty 50

Mr. Kumar Arya

Research Scholar, Faculty of Management Sciences, Siksha O‘ Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India. Email id: aryantripathy@yahoo.com

Online published on 17 September, 2018.

Abstract

The pharmaceuticalindustry in India is found to be ever raising industry since 90‘s. This growth lies with the proper utilization of resources, research and development, and technology. Due to the continuous growth of such industry, it has found that the Indian economy tends to grow with the growth of other industries. The economic condition of India is growing at a faster rate globally; it is only due to the better and continuous growth of firm‘s performances. But a sustainable growth will help the firm as well as the nation to meet the competition. The steady growth will help to take a major decision on further investment for long-term growth. Similarly, the pharmaceutical industry may not be a heavy industry but their performances for last few decades are found to be rising continuously. Hence this paper will try to find out the sustainable growth rate of Pharmaceutical companies that are listed in Nifty 50. Profit margin, debt-equity ratio, returns on equity, dividend payout ratio and return on total assets to sales will be compared to sustainable growth rate to understand the impact.

Top

Keywords

Financial Ratio, Nifty, Pharmaceutical Industry, Regression, Sustainable Growth Rate.

Top